Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Daniel Thwaites Gains: Why This Heritage Hospitality Stock Is Back in Focus

• Daniel Thwaites PLC (THW) appeared among the UK’s top equity gainers in a recent session, with a daily price advance of 10.50 per cent to a last traded price of 112.88 GBX, though no confirmed public catalyst has been identified for the move.

Ankur Sharma | 30 June 2026

Can Hemogenyx Pharmaceuticals Create the Next Breakthrough Cancer Therapy?

Unlike mature pharmaceutical companies that generate recurring commercial revenue, Hemogenyx's investment case is primarily driven by research progress, clinical development, intellectual property, regulatory milestones, and the long-term commercial potential of its therapeutic pipeline. As a result, the company offers significant growth opportunities but also …

Ishan Mudgal | 29 June 2026

Is Avacta Group plc's Drug Development Pipeline Worth Watching?

Although biotechnology companies typically experience periods of elevated volatility, Avacta continues to attract attention due to the long-term commercial potential of its proprietary platforms and expanding clinical pipeline.

Ishan Mudgal | 29 June 2026

Why Is LSE:FUM - Futura Medical plc Falling Today? Complete FTSE AIM Healthcare Stock Analysis

• Futura Medical plc shares declined 12.85% on 26 June 2026, making it one of the notable FTSE AIM losers.

Ankur Sharma | 29 June 2026

Why Is LSE:TCF - TheraCryf PLC Falling Today? Complete FTSE AIM Healthcare Stock Analysis

• TheraCryf PLC shares declined 8.51% on 26 June 2026, making it one of the notable FTSE AIM healthcare losers.

Ankur Sharma | 29 June 2026

Sareum Holdings Share Price News: Latest Reasons Behind the 8.70% Decline and What Investors Need to Know

• Sareum Holdings plc shares fell 8.70% on 26 June 2026, making it one of the notable FTSE AIM decliners.

Ankur Sharma | 29 June 2026

LSE:VAL - ValiRx PLC Drops Nearly 6%: Breaking FTSE AIM Stock News, Latest Catalysts and Investor Outlook

• Profit-taking and weak sentiment across speculative AIM biotechnology shares contributed to selling pressure.

Ankur Sharma | 29 June 2026

LSE:VAL - ValiRx PLC Drops Nearly 6%: Breaking FTSE AIM Stock News, Latest Catalysts and Investor Outlook

• Profit-taking and weak sentiment across speculative AIM biotechnology shares contributed to selling pressure.

Ankur Sharma | 29 June 2026

LSE:HVO Drops Today: Breaking hVIVO Share Price Analysis, Clinical Trials Outlook and Future Catalysts

• Profit-taking across healthcare growth stocks and weaker AIM market sentiment pressured the shares.

Ankur Sharma | 29 June 2026

Inspiration Healthcare Share Price Slides: Is This Medical Technology Stock Becoming a Buying Opportunity?

• Investors booked profits amid weaker sentiment across AIM-listed healthcare shares.

Ankur Sharma | 29 June 2026
Support

Hi! How can we help you today?

Loading…